10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Anticancer Effect of Deuterium Depleted Water - Redox Disbalance Leads to Oxidative Stress*

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The antiproliferation effect of deuterium depleted water (DDW) is well documented, but the mechanism remained elusive. Here three complementary proteomics approaches applied to A549 cells revealed a disbalance brought about by DDW in mitochondria between ROS production and neutralization, thus leading to oxidative stress in the cells. Subsequent validation by orthogonal approaches supported this scenario. Therefore, DDW has potential as an adjuvant in antitumor therapy, especially in the modalities inducing oxidative stress in cancer cells.

          Graphical Abstract

          Highlights

          • The antiproliferation effect of deuterium depleted water (DDW) was confirmed in a cell model.

          • DDW inhibits cell proliferation through causing a ROS disbalance in mitochondria.

          • DDW has a potential as an adjuvant in antitumor therapy.

          Abstract

          Despite the convincing empirical evidence that deuterium depleted water (DDW, 25–125 ppm deuterium) has anticancer effect, the molecular mechanism remains unclear. Here, redox proteomics investigation of the DDW action in A549 cells revealed an increased level of oxidative stress, whereas expression proteomics in combination with thermal profiling uncovered crucial role of mitochondrial proteins. In the proposed scenario, reversal of the normally positive deuterium gradient across the inner membrane leads to an increased export of protons from the matrix to intermembrane space and an increase in the mitochondrial membrane potential, enhancing the production of reactive oxygen species (ROS). The resulting oxidative stress leads to slower growth and can induce apoptosis. However, further deuterium depletion in ambient water triggers a feedback mechanism, which leads to restoration of the redox equilibrium and resumed growth. The DDW-induced oxidative stress, verified by traditional biochemical assays, may be helpful as an adjuvant to ROS-inducing anticancer therapy.

          Related collections

          Most cited references56

          • Record: found
          • Abstract: found
          • Article: not found

          Tracking cancer drugs in living cells by thermal profiling of the proteome.

          The thermal stability of proteins can be used to assess ligand binding in living cells. We have generalized this concept by determining the thermal profiles of more than 7000 proteins in human cells by means of mass spectrometry. Monitoring the effects of small-molecule ligands on the profiles delineated more than 50 targets for the kinase inhibitor staurosporine. We identified the heme biosynthesis enzyme ferrochelatase as a target of kinase inhibitors and suggest that its inhibition causes the phototoxicity observed with vemurafenib and alectinib. Thermal shifts were also observed for downstream effectors of drug treatment. In live cells, dasatinib induced shifts in BCR-ABL pathway proteins, including CRK/CRKL. Thermal proteome profiling provides an unbiased measure of drug-target engagement and facilitates identification of markers for drug efficacy and toxicity. Copyright © 2014, American Association for the Advancement of Science.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry.

            The direct detection of drug-protein interactions in living cells is a major challenge in drug discovery research. Recently, we introduced an approach termed thermal proteome profiling (TPP), which enables the monitoring of changes in protein thermal stability across the proteome using quantitative mass spectrometry. We determined the intracellular thermal profiles for up to 7,000 proteins, and by comparing profiles derived from cultured mammalian cells in the presence or absence of a drug we showed that it was possible to identify direct and indirect targets of drugs in living cells in an unbiased manner. Here we demonstrate the complete workflow using the histone deacetylase inhibitor panobinostat. The key to this approach is the use of isobaric tandem mass tag 10-plex (TMT10) reagents to label digested protein samples corresponding to each temperature point in the melting curve so that the samples can be analyzed by multiplexed quantitative mass spectrometry. Important steps in the bioinformatic analysis include data normalization, melting curve fitting and statistical significance determination of compound concentration-dependent changes in protein stability. All analysis tools are made freely available as R and Python packages. The workflow can be completed in 2 weeks.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM

              Activation of the p53 tumor suppressor can lead to cell cycle arrest. The key mechanism of p53-mediated arrest is transcriptional downregulation of many cell cycle genes. In recent years it has become evident that p53-dependent repression is controlled by the p53–p21–DREAM–E2F/CHR pathway (p53–DREAM pathway). DREAM is a transcriptional repressor that binds to E2F or CHR promoter sites. Gene regulation and deregulation by DREAM shares many mechanistic characteristics with the retinoblastoma pRB tumor suppressor that acts through E2F elements. However, because of its binding to E2F and CHR elements, DREAM regulates a larger set of target genes leading to regulatory functions distinct from pRB/E2F. The p53–DREAM pathway controls more than 250 mostly cell cycle-associated genes. The functional spectrum of these pathway targets spans from the G1 phase to the end of mitosis. Consequently, through downregulating the expression of gene products which are essential for progression through the cell cycle, the p53–DREAM pathway participates in the control of all checkpoints from DNA synthesis to cytokinesis including G1/S, G2/M and spindle assembly checkpoints. Therefore, defects in the p53–DREAM pathway contribute to a general loss of checkpoint control. Furthermore, deregulation of DREAM target genes promotes chromosomal instability and aneuploidy of cancer cells. Also, DREAM regulation is abrogated by the human papilloma virus HPV E7 protein linking the p53–DREAM pathway to carcinogenesis by HPV. Another feature of the pathway is that it downregulates many genes involved in DNA repair and telomere maintenance as well as Fanconi anemia. Importantly, when DREAM function is lost, CDK inhibitor drugs employed in cancer treatment such as Palbociclib, Abemaciclib and Ribociclib can compensate for defects in early steps in the pathway upstream from cyclin/CDK complexes. In summary, the p53–p21–DREAM–E2F/CHR pathway controls a plethora of cell cycle genes, can contribute to cell cycle arrest and is a target for cancer therapy.
                Bookmark

                Author and article information

                Journal
                Mol Cell Proteomics
                Mol. Cell Proteomics
                mcprot
                mcprot
                MCP
                Molecular & Cellular Proteomics : MCP
                The American Society for Biochemistry and Molecular Biology
                1535-9476
                1535-9484
                December 2019
                13 September 2019
                13 September 2019
                : 18
                : 12
                : 2373-2387
                Affiliations
                [1]Division of Physiological Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-17 165 Stockholm, Sweden
                Author notes
                ‡ To whom correspondence should be addressed. E-mail: Roman.Zubarev@ 123456ki.se .

                Author contributions: X.Z. and R.A.Z. designed research; X.Z. and M.G. performed research; X.Z., M.G., and A.C. analyzed data; X.Z., M.G., A.C., and R.A.Z. wrote the paper.

                Author information
                https://orcid.org/0000-0001-9839-2089
                Article
                RA119.001455
                10.1074/mcp.RA119.001455
                6885702
                31519768
                72ac0bda-cdd0-402a-bc24-f0604dc53b49
                © 2019 Zhang et al.

                Author's Choice—Final version open access under the terms of the Creative Commons CC-BY license.

                History
                : 1 April 2019
                : 22 August 2019
                Categories
                Research

                Molecular biology
                chemoproteomics,quantification,tandem mass spectrometry,cancer therapeutics,oxidative stress,anticancer,deuterium depleted water,proteomics,redox disbalance

                Comments

                Comment on this article